About the Authors
- Takuto Nakamura
-
Contributed equally to this work with: Takuto Nakamura, Satoko Sekimoto
Roles Formal analysis, Resources, Software, Writing – original draft, Writing – review & editing
Affiliations Department of Informatics, The University of Electro-communications, Tokyo, Japan, Japan Society for the Promotion of Science, Tokyo, Japan
- Satoko Sekimoto
-
Contributed equally to this work with: Takuto Nakamura, Satoko Sekimoto
Roles Data curation, Formal analysis, Writing – original draft, Writing – review & editing
Affiliation Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan
- Genko Oyama
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – original draft, Writing – review & editing
Affiliation Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan
- Yasushi Shimo
-
Roles Funding acquisition, Writing – review & editing
Affiliation Department of Informatics, The University of Electro-communications, Tokyo, Japan
- Nobutaka Hattori
-
Roles Funding acquisition, Writing – review & editing
* E-mail: nhattori@juntendo.ac.jp
Affiliation Department of Neurology, Juntendo University School of Medicine, Tokyo, Japan
- Hiroyuki Kajimoto
-
Roles Conceptualization, Investigation, Resources, Software, Writing – review & editing
Affiliation Department of Informatics, The University of Electro-communications, Tokyo, Japan
Competing Interests
NH has received speaker honoraria from Dai-Nippon Sumitomo, Otsuka, Takeda, Kyowa Hakko-Kirin, GSK, Nippon Boehringer Ingelheim, FP, Eisai, Kissei, Nihon Medi-physics, Novartis, Biogen Idec Japan, AbbVie, Astellas, Boston Scientific Japan, Sanofi, Pfizer Japan, Alexion, Mylan N.V, MSD, Daiichi Sankyo, and MDS. NH has received consultancies and subcontracting from Dai-Nippon Sumitomo, Biogen Idec, Otsuka, Takeda, Kyowa Hakko-Kirin, Meiji Seika, Hisamitsu, Kao. GO has received speaker honoraria from Medtronic, Boston Scientific, Otsuka Pharmaceutical, Sumitomo Dainippon Pharma, Novartis Pharma, MSD, Nihon Medi-Physics, FP Pharmaceutical Corporation, and Kyowa Hakko Kirin, and Abbvie. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.